Ashmore Group (ASHM.L) — Company Research
Last Updated: 11 September 2026
Ashmore Group plc is a London-listed fund manager that does one thing: emerging markets. It runs external debt, local currency, corporate debt, blended debt, equity and alternatives strategies, almost entirely for institutional clients, and its earnings rise and fall with emerging-market sentiment in a way few other FTSE 250 financials do. FY2026, the year to 30 June 2026, was the first genuine turn in several years — assets under management rose 13% to US$54.0bn and the group returned to net inflows of US$2.7bn after a run of outflows — yet net revenue still fell 2% to £140.5m and the shares fell on results day. This report separates the recovery in assets from the continued erosion in fee income. No analyst ratings or price targets appear anywhere in it. Price action is on our Live Charts page.
1. Company Snapshot
| Field | Value |
|---|---|
| Listing | London Stock Exchange, LSE: ASHM (ISIN GB00B132NW22) |
| Sector | Asset management — specialist emerging markets |
| Headquarters | 16 Palace Street, London (relocated April 2026) |
| Employees | Average Group headcount of 278 in FY2026, across 13 offices worldwide |
| CEO / Leadership | Mark Coombs, founder and Chief Executive, confirmed in post as signatory of the FY2026 results on 7 September 2026; Tom Shippey, Group Finance Director |
| Revenue (FY2026) | £140.5m net revenue, down 2% on FY2025's £144.1m (adjusted net revenue £135.6m) |
| Profit before tax (FY2026) | £126.9m, up 17%; profit attributable to shareholders £103.3m, up 27% |
| Assets under management | US$54.0bn at 30 June 2026, up 13% year on year |
| Market cap | Approximately £1.4bn on 650.1m shares in issue at about 217p (September 2026); approximately £1.55bn on the 711.9m shares issued, of which the Employee Benefit Trust held 61.9m, or 8.7%, at 30 June 2026 |
| Share price | About 217p (early September 2026) |
| Index membership | FTSE 250 |
| Balance sheet | No debt; £364.7m of cash and deposits and £794.3m of total equity at 30 June 2026 |
| Fiscal year end | 30 June |
2. Bull and Bear Case
Bull Case
- The flow picture has genuinely turned: FY2026 produced net inflows of US$2.7bn against a US$5.8bn net outflow in FY2025. Gross subscriptions rose 92% to US$12.5bn while gross redemptions fell 20% to US$9.8bn — both sides of the ledger moved the right way, not just one.
- Investment performance has recovered sharply: 77% of assets under management were outperforming over one year at 30 June 2026, against 57% a year earlier. In a business where flows follow performance with a lag, that matters more than the current year's revenue line.
- A fortress balance sheet with no debt: £364.7m of cash and deposits, £609.5m of total capital resources against a Board requirement of £88.0m, and zero borrowings. The 16.9p dividend has been held flat through a multi-year revenue decline without recourse to leverage.
- Japan Post Insurance validates the franchise: the 31 March 2026 alliance brought an incremental US$1bn commitment across fixed income, Impact Debt and listed equities, and gives JPI the right to acquire up to 2.9% of Ashmore's equity in the market. The shares rose 5.8% on the day.
- Diversification away from EM debt is actually happening: equities reached US$10.0bn, or 18.5% of assets, up from US$7.5bn, and alternatives grew 25% with new private market funds in Saudi Arabia and the initial funding of Ashmore Healthcare International.
Bear Case
- Core earnings are still falling: adjusted diluted EPS fell to 5.0p in FY2026 from 7.1p in FY2025 and 18.7p in FY2022. The headline 28% rise in statutory EPS to 15.04p came from seed capital gains, not from the fee-earning business.
- Fee margin compression is structural, not cyclical: the net management fee margin has fallen every year from 39bps in FY2022 to 34bps in FY2026, as mix shifts toward lower-margin overlay, liquidity and local-currency mandates. Assets can grow while revenue shrinks, and in FY2026 they did exactly that.
- Profit quality is poor: FY2026 seed capital gains were £82.5m against £40.1m in FY2025 and a £49.9m loss in FY2022. These are mark-to-market swings on the group's own capital, not repeatable operating income, and they dominate reported profit.
- Key-man concentration around the founder: Mark Coombs has led the business since 1998 and is reported to hold roughly 32% of the equity. Succession is unresolved and the shareholder register is unusually concentrated for a FTSE 250 company.
- Everything depends on one asset class staying in favour: with 78% of assets in emerging market fixed income, a reversal in EM sentiment or a sustained dollar rally hits assets, flows and seed capital simultaneously. There is no offsetting business line.
3. Business Segments
Ashmore reports as a single operating segment but discloses assets under management and fee margin by investment theme. The revenue shares below are derived by applying each theme's disclosed net management fee margin to its closing assets at 30 June 2026; they are an approximation of where fee income originates rather than a reported segmental split.
| Segment / category | % of revenue | What it is |
|---|---|---|
| Equities | About 26% (derived) | US$10.0bn of assets, 18.5% of the total, at a 48bps fee margin. Includes all-cap, frontier and EM ex-China strategies, and has been the fastest-growing fee pool, up from US$7.5bn. |
| Local currency | About 23% (derived) | US$17.4bn of assets, 32.2% of the total and the largest theme, but at just 25bps the lowest-margin one. Includes US$9.8bn of overlay and liquidity mandates, up from US$7.9bn a year earlier. |
| Blended debt | About 18% (derived) | US$11.4bn of assets, 21.1% of the total, at a 30bps margin. Multi-theme mandates giving clients a single allocation across EM debt sub-asset classes. |
| External debt | About 14% (derived) | US$7.8bn of assets, 14.4% of the total, at a 32bps margin. Hard-currency sovereign and quasi-sovereign EM debt, the group's founding strategy. |
| Corporate debt | About 9% (derived) | US$5.4bn of assets, 10.0% of the total, at a 31bps margin. EM corporate credit across investment grade and high yield. |
| Alternatives | About 10% (derived) | US$2.0bn of assets, only 3.7% of the total but at 91bps by far the highest margin. Private equity, private debt and thematic vehicles including Saudi industrials and education funds and Ashmore Healthcare International. |
Fixed income in aggregate accounted for US$42.0bn, or 77.8% of total assets, at a blended 29bps. Local offices outside London held US$8.9bn, or 16% of group assets, and contributed 40% of adjusted EBITDA. Retail-sourced assets rose from 4% to 5% of the group total.
4. Business Model and Moat
How it makes money. Ashmore charges a management fee on assets under management, supplemented by occasional performance fees. FY2026 adjusted revenue comprised net management fees of £128.2m, performance fees of just £1.4m and other revenue of £5.8m. Because performance fees have become immaterial, the revenue line is essentially average assets multiplied by the blended fee margin — which is why a 13% rise in closing assets still produced a 2% fall in revenue.
What the franchise actually is. Thirty-four years of continuous emerging-market specialisation, a 13-office network with local presence in markets including Colombia, Indonesia, Saudi Arabia and now Mexico and Qatar, and institutional relationships measured in decades — the Japan Post Insurance relationship runs to fifteen years. For a large pension fund or insurer allocating to EM debt, the shortlist of managers with this depth of local coverage is short.
Where the model is under pressure. The blended net management fee margin has fallen from 39bps to 34bps in four years. Part of this is deliberate mix — growing the low-fee overlay and liquidity business adds assets and scale — and part is competitive pressure from passive EM debt products, which Ashmore's own risk disclosures identify as a strategic threat.
How the balance sheet is used. Ashmore seeds its own funds with group capital, holding £323.5m of seed investments at 30 June 2026 after £172.9m of realisations and £62.5m of additions, split 42% fixed income, 28% equities and 30% alternatives, with £82.5m of undrawn commitments. This accelerates new product launches but injects substantial mark-to-market volatility into reported profit: £82.5m of gains in FY2026 against a £49.9m loss in FY2022.
Cost discipline. Variable compensation flexes with profitability, which cushions the downside but also means that outsized seed gains drive an outsized comp charge. FY2026 adjusted EBITDA margin was 26% on that basis, or 40% excluding the seed-linked variable compensation effect, against 37% in FY2025.
5. Financial Health
Figures below are taken from Ashmore's audited final results announcements for each financial year, published via RNS. Ashmore reports in sterling with a 30 June year end and publishes half-yearly, not quarterly, financial statements.
| Fiscal Year | Revenue (£m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| FY2022 | 262.5 | — | 12.7p‡ | 18.7p | 16.65p | Nil |
| FY2023 | 196.4 | −25.2% | 12.2p | 12.7p | 16.90p | Nil |
| FY2024 | 189.3 | −3.6% | 13.6p | 10.5p | 16.90p | Nil |
| FY2025 | 144.1 | −23.9% | 11.77p | 7.1p | 16.90p | Nil |
| FY2026 | 140.5 | −2.5% | 15.04p | 5.0p | 16.90p | Nil |
‡ FY2022 statutory diluted EPS is derived: the FY2023 final results state that FY2023's 12.2p was 4% lower than the prior year, implying approximately 12.7p. Ashmore has carried no borrowings in any of the five years above; every audited balance sheet reviewed states that the group continues to have no debt. The only balance-sheet obligations of that character are operating lease liabilities, which totalled £16.8m at 30 June 2026. Closing assets under management across the same period ran US$64.0bn, US$55.9bn, US$49.3bn, US$47.6bn and US$54.0bn.
| Quarter / Half | Revenue | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| H2 FY2026 (Jan–Jun 2026) | £72.5m† | 1.9p† | 4.9p† |
| H1 FY2026 (Jul–Dec 2025) | £68.0m | 3.1p | 10.1p |
| H2 FY2025 (Jan–Jun 2025) | £63.1m† | 2.3p† | 6.4p† |
| H1 FY2025 (Jul–Dec 2024) | £81.0m | 4.8p | 5.4p |
| FY2026 total | £140.5m | 5.0p | 15.04p |
† Ashmore does not publish standalone second-half accounts. H2 figures are derived by subtracting the reported first half from the audited full year. H1 FY2026 itself was strong on a statutory basis, with profit before tax of £81.9m, up 64%, and £55.4m of pre-tax seed capital profit; the interim dividend was held at 4.8p. Between results dates Ashmore issues quarterly assets-under-management statements only: US$48.7bn at 30 September 2025, US$52.5bn at 31 December 2025, US$50.7bn at 31 March 2026 and US$54.0bn at 30 June 2026.
Cash generation remains solid relative to the size of the business. Cash generated from operations was £52.2m in FY2026 with depreciation and amortisation of £3.6m, reported operating profit of £71.7m and adjusted operating profit of £32.1m. The gap between operating profit and the £126.9m profit before tax is largely seed capital gains and interest income, which sit below the operating line.
6. Valuation
Raw metrics, September 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | Approximately £1.42bn (650,149,952 shares in issue at about 217p). On the 711.9m shares issued before deducting the 61.9m held by the Employee Benefit Trust, the figure is about £1.55bn. The lower figure is used throughout this section. |
| Trailing P/E (GAAP) | About 14.5x on FY2026 statutory diluted EPS of 15.04p. On adjusted diluted EPS of 5.0p, which strips out seed capital gains and better reflects the fee-earning business, the same share price implies roughly 43x — the gap between those two numbers is the single most important thing in this table. |
| P/E (forward) | n/a — Ashmore publishes no earnings guidance, and this report does not use third-party consensus estimates. |
| P/S (TTM) | About 10.1x (market cap £1.42bn / FY2026 net revenue £140.5m). On adjusted net revenue of £135.6m the multiple is about 10.5x. |
| Enterprise value | About £1.07bn (market cap £1.42bn + lease liabilities £16.8m − cash and deposits £364.7m, per the 30 June 2026 balance sheet). Ashmore carries no borrowings, so cash is the only material bridging item. The £323.5m seed capital portfolio is not deducted here, although it is a realisable asset. |
| EV/EBITDA (TTM) | About 14.2x (EV £1.07bn / EBITDA £75.3m; EBITDA = FY2026 reported operating profit £71.7m + D&A £3.6m). On adjusted operating profit of £32.1m plus the same D&A, the multiple would be roughly 30x. Note that seed capital gains largely sit below the operating line, so this measure is less distorted than profit before tax. |
| P/FCF | About 27x (market cap £1.42bn / FCF £52.2m; FCF = FY2026 cash generated from operations £52.2m less capital expenditure, which Ashmore does not disclose as a separate line in its results announcement and which is immaterial for an asset manager of this size — D&A of £3.6m indicates the scale involved). |
| 52-week high | 275.40p |
| 52-week low | 145.90p |
| Dividend yield | About 7.8% (16.9p total declared for FY2026 at a share price of about 217p), held flat for four consecutive years |
| Short interest (% of float) | n/a — no net short position at or above the FCA's 0.5% public disclosure threshold was identified against Ashmore on the FCA short positions register as at September 2026. Positions below that threshold are not published in the UK. |
| Days to cover | n/a — not calculable, since UK disclosure is position-based rather than aggregate-share-count based and no disclosable position was outstanding |
7. What Are They Building
A second leg in equities. Equity assets reached US$10.0bn at 30 June 2026, 18.5% of the group and up from US$7.5bn, with European institutional demand concentrated in all-cap strategies. At a 48bps fee margin against 29bps for fixed income, every dollar moved from debt to equity is worth substantially more revenue.
Private markets and thematic alternatives. Alternatives assets grew 25% year on year. New vehicles include thematic private equity and private debt funds in Saudi Arabia targeting industrials and education, and the initial funding of Ashmore Healthcare International Limited. At 91bps this is the highest-margin part of the business, albeit from a small US$2.0bn base.
Local network expansion. Ashmore Mexico received regulatory approval in May 2026 to operate as an independent corporate investment adviser, and a new business was registered in Doha, Qatar. Local office assets grew 13% to US$8.9bn and now generate 40% of adjusted EBITDA from 16% of assets — a disproportionate contribution that explains the continued investment.
Distribution reach. The Japan Post Insurance alliance of 31 March 2026 added an incremental US$1bn commitment and a potential 2.9% equity stake. Retail and intermediary-sourced assets grew from 4% to 5% of the group, with digital distribution being built out in Indonesia and Saudi Arabia.
Product breadth within EM. Frontier blended debt, Impact Debt and an EM equity ex-China strategy launched in FY2025 have all been seeded from the group's own capital, which is the mechanism by which Ashmore converts balance-sheet strength into new fee pools.
8. Peer Comparison
| Peer | Market cap (September 2026) | Key 2025/2026 metric |
|---|---|---|
| Schroders plc (LSE: SDR) | Approximately £9.1–9.3bn (August/September 2026, companiesmarketcap.com) | Record assets under management of £824bn with operating profit up 25%. On 12 February 2026 Nuveen agreed to acquire Schroders for US$13.5bn (£9.9bn), creating a group with close to US$2.5tn of assets. |
| Aberdeen Group plc (LSE: ABDN) | Approximately £4.5–4.6bn (August 2026, companiesmarketcap.com and stockanalysis.com) | Assets under management and administration up 15% to £108bn in one division at the H1 2026 results. Roughly three times Ashmore's market value on a far more diversified UK-centric book. |
| Man Group plc (LSE: EMG) | Approximately US$4.5bn (2 September 2026) | Record assets under management of US$253.6bn at 30 June 2026, up 11% in the quarter. Alternatives-led and performance-fee driven, which is the earnings model Ashmore's alternatives push is edging toward. |
| Jupiter Fund Management plc (LSE: JUP) | Approximately US$1.07bn (30 July 2026) | Record assets under management of £68.4bn at the H1 2026 stage, up 36% largely through the CCLA acquisition, with Q1 2026 net inflows of £1.5bn. The closest UK peer by size and the clearest example of growth through acquisition rather than flows. |
| Franklin Resources Inc. (NYSE: BEN) | Approximately US$17.2bn (August 2026, companiesmarketcap.com) | Record US$1.8tn of assets under management with US$18.4bn of long-term net inflows reported for Q3 FY2026. Competes directly with Ashmore in institutional EM debt mandates at far greater scale. |
Ashmore is the smallest of this group by market capitalisation and the only one that is a pure emerging-markets specialist. Results dates across UK and US asset managers are tracked on the ChartsView Economic Calendar.
9. Insider Activity
Chief Executive Mark Coombs founded Ashmore's predecessor business within ANZ and has run the group since 1998. He is reported to hold approximately 32% of the equity, roughly 209.9m shares, making him by a wide margin the largest shareholder and the reason key-man concentration appears in the risk section below. That stake has not been reported as changing during 2026. The disclosed director and PDMR dealings for the year to date are set out below.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| Fay Shippey (PCA of Tom Shippey) | 27 May 2026 | Sell | 15,000 | 214.1p | £32,115 | Person closely associated |
| Fay Shippey (PCA of Tom Shippey) | 26 May 2026 | Sell | 75,000 | 213.3p | £159,975 | Person closely associated |
| Clive Adamson | 31 Mar 2026 | Buy | 65 | 209.3p | £136 | Purchase funded from interim dividend |
| Tom Shippey | 16 Mar 2026 | Sell | 5,723 | 208.0p | £11,904 | Sale following nil-cost award vesting of 5,723 shares |
The pattern is unremarkable: two small award-related disposals by the Group Finance Director and a person closely associated with him, and a token dividend-funded purchase by a non-executive director. Separately, on 12 February 2026 BlackRock notified that its holding had fallen below 5% from 5.72% — an institutional disclosure rather than an insider dealing.
10. Key Risks
- Emerging-market sentiment: assets, flows and seed capital gains all key off the same variable. FY2026's recovery followed a strong year for EM indices; a reversal, or a sustained dollar rally, would compress all three simultaneously with no offsetting business line.
- Fee margin erosion: the net management fee margin has fallen from 39bps in FY2022 to 34bps in FY2026. FY2026 demonstrated that assets can rise 13% while revenue falls 2%, which is the clearest possible illustration of the problem.
- Earnings quality and seed capital volatility: £82.5m of seed capital gains in FY2026, £40.1m in FY2025 and a £49.9m loss in FY2022. Reported profit before tax and statutory EPS swing on mark-to-market movements in the group's own investments rather than on the fee business.
- Key-man and register concentration: Mark Coombs has led the business for over a quarter of a century and holds roughly 32% of the shares. No succession plan has been announced, and Ashmore's own risk disclosures cite the inability to attract and retain key employees.
- Client and redemption concentration: approximately 95% of assets are institutional and gross redemptions were US$9.8bn in FY2026, equal to about 21% of opening assets. A small number of large mandate decisions can move group assets materially in either direction.
- Passive competition: Ashmore's own filings identify the threat of passive products to its active fee model. EM debt index funds compete directly on the lowest-margin, most commoditised end of Ashmore's book.
- Currency mismatch: the majority of fee income is denominated in US dollars while costs and reporting are in sterling, and the group hedges only up to two-thirds of budgeted dollar fee income, leaving residual translation and transaction exposure.
- Dividend cover: the 16.9p dividend has been held flat for four years while adjusted diluted EPS has fallen from 18.7p to 5.0p. It is currently covered by statutory earnings of 15.04p only because of seed gains, and by cash and capital resources rather than by core operating profit.
11. Recent Developments
- 05 Sep 2025 — FY2025 final results. Assets under management of US$47.6bn, profit before tax of £108.6m, diluted EPS of 11.77p and the total dividend maintained at 16.9p.
- 14 Oct 2025 — Q1 FY2026 assets statement. Assets rose 2% to US$48.7bn at 30 September 2025.
- 06 Nov 2025 — Annual General Meeting held with all resolutions put to shareholders.
- 15 Jan 2026 — Q2 FY2026 assets statement. Assets rose 8% to US$52.5bn at 31 December 2025.
- 12 Feb 2026 — H1 FY2026 results. Profit before tax of £81.9m, up 64%, diluted EPS of 10.1p, up 89%, and the interim dividend held at 4.8p. Seed capital contributed £55.4m of pre-tax profit. BlackRock separately notified that its holding had fallen below 5%.
- 31 Mar 2026 — Japan Post Insurance alliance announced. An incremental US$1bn commitment across fixed income, Impact Debt and listed equities, with JPI permitted to acquire up to 2.9% of Ashmore's equity in the market. The shares rose 5.8%.
- 16 Apr 2026 — Q3 FY2026 assets statement. Assets fell 3.4% to US$50.7bn at 31 March 2026 amid Middle East geopolitical volatility, including disruption around the Strait of Hormuz.
- 14 Jul 2026 — Q4 FY2026 assets statement. Assets rose 7% in the quarter to US$54.0bn, driven by US$2.0bn of investment performance and US$1.3bn of net inflows.
- 07 Sep 2026 — FY2026 final results. Assets up 13% to US$54.0bn, profit before tax up 17% to £126.9m, attributable profit up 27% to £103.3m, statutory diluted EPS up 28% to 15.04p, net revenue down 2% to £140.5m and the final dividend held at 12.1p for a 16.9p total. The shares fell on the day despite the profit beat.
- 08 Sep 2026 — Negative sell-side reaction to the results. Deutsche Bank reiterated a negative stance while raising its price target, and Cavendish also reiterated a negative rating. ChartsView reports these as events, not as recommendations, and takes no view on them.
12. Key Dates
- 14 Oct 2026 — Q1 FY2027 assets under management statement, the only forward event currently listed on Ashmore's financial calendar
- Expected Nov 2026 — 2026 Annual General Meeting, based on the 6 November 2025 precedent; the notice had not been published as at 11 September 2026
- 06 Nov 2026 — record date for the FY2026 final dividend of 12.1p per share
- 07 Dec 2026 — payment date for the FY2026 final dividend
- Expected Jan 2027 — Q2 FY2027 assets under management statement, based on the 15 January 2026 precedent
- Expected Feb 2027 — H1 FY2027 interim results, based on the 12 February 2026 precedent
The ex-dividend date for the final dividend was not stated explicitly in the FY2026 results announcement; on the standard London timetable it would fall the business day before the 6 November 2026 record date. Ashmore and other UK asset managers are discussed on the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Loading research report…
13. Thesis Verdict
The central thesis. Ashmore Group is a pure emerging-markets fund manager that earns almost all of its revenue from management fees charged on assets under management, with performance fees now immaterial at £1.4m in FY2026. FY2026 saw assets rise 13% to US$54.0bn with net inflows of US$2.7bn, the first meaningful return to inflows after several years of redemptions, and profit before tax up 17% to £126.9m. Net revenue nonetheless fell 2% to £140.5m because the blended net management fee margin slipped again, to 34bps from 39bps in FY2022, and adjusted diluted EPS fell to 5.0p even as statutory EPS rose to 15.04p on £82.5m of seed capital gains. The balance sheet carries no debt, £364.7m of cash and deposits, and a 16.9p dividend held flat for a fourth consecutive year.
What would confirm or break it. Confirmation would come from the Q1 FY2027 assets under management statement on 14 October 2026 showing continued net inflows, and from the fee margin stabilising so that asset growth finally converts into revenue growth. The thesis breaks if emerging-market sentiment reverses and takes assets, flows and seed capital gains down together, if the fee margin keeps compressing so that rising assets continue to produce falling revenue, or if the flat 16.9p dividend comes under pressure as adjusted earnings cover thins to 5.0p.
Watchpoints
- ConfirmsQ1 FY2027 assets under management statement (33 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "The flow picture has genuinely turned:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "Emerging-market sentiment:" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 11 Sep 2026.
